Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Hallux Inc logo — A specialty pharmaceutical company developing therapeutic so...

Hallux Inc

A specialty pharmaceutical company developing therapeutic solutions for common podiatric & dermatologic disorders.

Founded 2012 United States Laguna Hills, United States 5 employees Venture round Total: $18.71M Biotechnology, Design +1

General Information

Company Name Hallux Inc
Founded Year 2012
Location United States Laguna Hills, United States
Employees 5
Industries Biotechnology, Design, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Hallux Inc. To contact Hallux Inc, visit halluxinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hallux Inc compare?

A PDF of Hallux Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hallux Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hallux Inc

Hallux Inc is an innovative specialty pharmaceutical company focused on developing safe and highly effective breakthrough solutions for common infections of the toe, nail, and foot. The company's lead therapeutic candidate, Hallux Subungual Gel (HSG), is a novel terbinafine topical dosage form designed for treating toenail fungus, the most common nail disorder seen by podiatrists and dermatologists. The product is set to commence a Phase 2 efficacy, tolerability, and PK study in more moderately infected patients enrolled from OrthoArizona, a premier foot and ankle institute serving the greater Phoenix area. It is estimated that Podiatrists treat over 7 million patients a year for toenail fungus using routine nail debridement and Rx/OTC topicals, none of which work very well. Hallux aims to provide patients a cure rate exceeding oral terbinafine without systemic risk or the burden of daily pills for many months. Founded in 2012 and headquartered in the United States, Hallux Inc recently received a $9.40M Venture Round investment on 13 April 2022. The company is focused on achieving FDA and global registration of HSG and providing patients with highly effective topical therapy to cure fungal infections that have plagued many people worldwide for years. With a focus on Biotechnology and Health Care, Hallux Inc presents a promising investment opportunity in the pharmaceutical sector.

Business keywords: pharmaceutical company, therapeutic solutions, podiatric disorders, dermatologic disorders, specialty pharmaceuticals, toenail fungus treatment, terbinafine topical dosage form, clinical trial, FDA registration, global registration, topical therapy, foot and ankle health, medical innovation, clinical research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $9.40M -
13 Apr 2022
Debt Financing $2.21M -
01 Nov 2018
Series A $7.10M 1
Deerfield
16 Dec 2015

Hallux Inc Alternatives & Competitors

Hallux Inc vs
Chance Pharmaceuticals 畅溪制药
Chance Pharmaceuticals 畅溪制药 China

A clinical-stage biotech company focusing on discovering, developing and commercializing inhalation...

Series C
3 employees
Biotechnology, Health Care
Hallux Inc vs
Trimel Pharmaceuticals
Trimel Pharmaceuticals

Pioneering innovative solutions for male hypogonadism, female sexual dysfunction, and respiratory di...

Post-IPO Equity
Biotechnology, Health Care
Hallux Inc vs
HEART METABOLICS LTD
HEART METABOLICS LTD Ireland

Heart Metabolics is pioneering a pharmaceutical therapy for the treatment of hypertrophic cardiomyop...

Series A
1 employees
Biotechnology, Health Care

FAQ About Hallux Inc

A specialty pharmaceutical company developing therapeutic solutions for common podiatric & dermatologic disorders.
Hallux Inc was founded in 2012.
Hallux Inc is headquartered in Laguna Hills, United States.
Hallux Inc operates in Biotechnology, Design and Health Care. Its work centres on pharmaceutical company, therapeutic solutions, podiatric disorders and dermatologic disorders.
Hallux Inc has approximately 5 employees.
Hallux Inc has completed 3 funding rounds, raising a total of $18.71M. The latest funding stage is Venture round.
Top alternatives and competitors to Hallux Inc include Chance Pharmaceuticals 畅溪制药, Trimel Pharmaceuticals, HEART METABOLICS LTD, QRxPharma, Veloxis Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hallux Inc and Chance Pharmaceuticals 畅溪制药 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hallux Inc, https://bouncewatch.com/company/hallux-inc, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes